Surveying, Assessing and Analysing the Pharmaceutical Sector in the 25 EU Member States

The Austrian Health Institute (Osterreichisches Bundesinstitut fur Gesundheitswesen, OBIG) was commissioned by the European Commission, Directorate-General (DG) Competition/ Unit B-2 Basic Industry, Chemicals and Pharmaceuticals in Brussels to provide an in-depth and comprehensive description of the pharmaceutical system in each of the 25 Member States. The project started end of December 2005, and the report of the study “Surveying, Assessing and Analysing the Pharmaceutical Sector in the 25 EU Member States” was submitted to the European Commission in July 2006.